Article Details
Retrieved on: 2025-08-09 18:52:18
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Less than weeks after stepping down, Prasad will return to lead CBER “at the FDA's request,” according to an HHS spokesperson, marking the latest ...
Article found on: www.biopharmadive.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here